EA200901656A1 - СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ ITPKb - Google Patents

СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ ITPKb

Info

Publication number
EA200901656A1
EA200901656A1 EA200901656A EA200901656A EA200901656A1 EA 200901656 A1 EA200901656 A1 EA 200901656A1 EA 200901656 A EA200901656 A EA 200901656A EA 200901656 A EA200901656 A EA 200901656A EA 200901656 A1 EA200901656 A1 EA 200901656A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
compositions
itpkb
inhibitors
itpkb inhibitors
Prior art date
Application number
EA200901656A
Other languages
English (en)
Inventor
Бадри Бурсулая
Дай Чэн
Цзицин Цзян
Доналд С. Караневски
И Лю
Шифэн Пань
Йонцинь Вань
Ся Ван
Юньфэн Си
Ян Ян
Original Assignee
Айрм Ллк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Айрм Ллк filed Critical Айрм Ллк
Publication of EA200901656A1 publication Critical patent/EA200901656A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

В заявке описаны новый класс соединений, фармацевтические композиции, включающие такие соединения, и способы применения таких соединений для лечения или предупреждения заболеваний или нарушений, связанных с аномальной или нарушенной регуляцией активности В-клеток, в особенности заболеваний или нарушений, которые включают аберрантную активацию инозит-1,4,5-трифосфат-3-киназы В (ITPKb).
EA200901656A 2007-06-15 2008-06-12 СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ ITPKb EA200901656A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94435407P 2007-06-15 2007-06-15
PCT/US2008/066664 WO2008157210A1 (en) 2007-06-15 2008-06-12 Compounds and compositions as itpkb inhibitors

Publications (1)

Publication Number Publication Date
EA200901656A1 true EA200901656A1 (ru) 2010-06-30

Family

ID=39673403

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200901656A EA200901656A1 (ru) 2007-06-15 2008-06-12 СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ ITPKb

Country Status (16)

Country Link
US (2) US8178526B2 (ru)
EP (1) EP2167498B1 (ru)
JP (1) JP2010529993A (ru)
KR (1) KR20100020997A (ru)
CN (1) CN101743243A (ru)
AT (1) ATE481400T1 (ru)
AU (1) AU2008266185B2 (ru)
BR (1) BRPI0813929A2 (ru)
CA (1) CA2688487A1 (ru)
DE (1) DE602008002600D1 (ru)
EA (1) EA200901656A1 (ru)
ES (1) ES2351545T3 (ru)
MX (1) MX2009013215A (ru)
PL (1) PL2167498T3 (ru)
PT (1) PT2167498E (ru)
WO (1) WO2008157210A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2274302A2 (en) * 2008-04-04 2011-01-19 Irm Llc Compounds and compositions as itpkb inhibitors
CN108689876B (zh) * 2018-06-28 2020-11-27 苏州东南药业股份有限公司 一种8-(2-羟基苯甲酰胺基)辛酸钠的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692575B1 (fr) 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0959074A3 (en) 1992-12-17 2000-06-07 Pfizer Inc. Substituted pyrazoles as CRF antagonists
AU6517196A (en) 1995-07-13 1997-02-10 Knoll Aktiengesellschaft Piperazine derivatives as therapeutic agents
US6727264B1 (en) 2001-07-05 2004-04-27 Synaptic Pharmaceutical Corporation Substituted anilinic piperidines as MCH selective antagonists
GB0228417D0 (en) 2002-12-05 2003-01-08 Cancer Rec Tech Ltd Pyrazole compounds
US7595148B2 (en) * 2003-01-25 2009-09-29 Irm Llc Methods and compositions for modulating T lymphocytes
BRPI0410746A (pt) 2003-05-19 2006-06-27 Irm Llc compostos e composições imunossupressoras
WO2005019182A1 (en) 2003-08-20 2005-03-03 Bayer Healthcare Ag Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
JP2007507540A (ja) * 2003-10-02 2007-03-29 アイアールエム・リミテッド・ライアビリティ・カンパニー タンパク質キナーゼ阻害剤としての化合物および組成物
MX2007011316A (es) * 2005-03-15 2007-11-12 Irm Llc Compuestos y composiciones como inhibidores de cinasa de proteina.
TW200817375A (en) 2006-07-21 2008-04-16 Irm Llc Compounds and compositions as ITPKB inhibitors

Also Published As

Publication number Publication date
BRPI0813929A2 (pt) 2017-05-09
CA2688487A1 (en) 2008-12-24
AU2008266185A1 (en) 2008-12-24
US20120202782A1 (en) 2012-08-09
MX2009013215A (es) 2010-01-25
PT2167498E (pt) 2010-11-29
CN101743243A (zh) 2010-06-16
ES2351545T3 (es) 2011-02-07
KR20100020997A (ko) 2010-02-23
EP2167498B1 (en) 2010-09-15
WO2008157210A1 (en) 2008-12-24
US8178526B2 (en) 2012-05-15
US20100184748A1 (en) 2010-07-22
PL2167498T3 (pl) 2011-03-31
DE602008002600D1 (de) 2010-10-28
EP2167498A1 (en) 2010-03-31
AU2008266185B2 (en) 2011-12-08
ATE481400T1 (de) 2010-10-15
JP2010529993A (ja) 2010-09-02

Similar Documents

Publication Publication Date Title
WO2008011611A3 (en) Compounds and compositions as itpkb inhibitors
TN2012000081A1 (en) Compounds and compositions as protein kinase inhibitors
MX2010010877A (es) Compuestos y composiciones como inhibidores de itpkb.
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
MX2009004716A (es) Compuestos y composiciones en la forma de inhibidores de quinasa de proteina.
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
NO20090596L (no) Antivirale fosfinatforbindelser
MX2010009752A (es) Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
MA32393B1 (fr) Composés et compositions servant d'inhibiteurs de kinases
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
HK1136283A1 (en) Compounds for the prevention and treatment of cardiovascular diseases
MX2010009207A (es) Compuestos y composiciones heterociclicos como inhibidores de c-kit y pdgfr cinasa.
ECSP088852A (es) Azolopirimidinas como inhibidores de la actividad canabinoidea 1
MX2012002366A (es) Agonistas novedosos de receptores beta 3 andrenergicos derivados de pirrolidina.
MX2009010207A (es) Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c.
EA201100311A1 (ru) Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы
MY144970A (en) Heterocyclic compounds
MX2008002166A (es) Compuestos y composiciones como mimeticos de trombopoietina (tpo).
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
MX2009007911A (es) Inhibidores de proteina tirosina fosfatasa 1b aromaticos fusionados.
MX2009006170A (es) Compuestos y composiciones como inhibidores de cinasa.
PH12014502623A1 (en) Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
ES2333026T3 (es) Derivados de ciclohexil-1,4-diamina sustituidos.